Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease

23 May 2022

Abstract excerpt

Microglia, the resident immune cells of the central nervous system (CNS), are responsible for maintaining homeostasis in the brain by clearing debris and are suggested to be inefficient in Alzheimer's Disease (AD), a progressive neurodegenerative disorder for which there is no disease-modifying drug. Besides pathological approaches, unbiased evidence from genome-wide association studies (GWAS) and gene network...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neuroinflammation and Neurodegeneration Mechanisms
Share to Neurological Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35677758
DOI: 10.3389/fncel.2022.894601

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s DiseasePMID 35677758Read ↗

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentialsSemantic proximity Read ↗

TREM1 facilitates microglial phagocytosis of amyloid beta.Semantic proximity Read ↗

Novel Master Regulators of Microglial Phagocytosis and Repurposed FDA-approved Drug for Treatment of Alzheimer DiseaseSemantic proximity Read ↗

PLCG2 signaling and genetic resilience in Alzheimer's disease.Semantic proximity Read ↗

Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s diseaseSemantic proximity Read ↗

Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence RiskSemantic proximity Read ↗

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and DevelopmentSemantic proximity Read ↗

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's DiseaseSemantic proximity Read ↗

Adhesion G protein-coupled receptor ADGRG1 promotes protective microglial response in Alzheimer’s diseaseSemantic proximity Read ↗

Roles of microglia in Alzheimer’s disease and impact of new findings on microglial heterogeneity as a target for therapeutic interventionSemantic proximity Read ↗

The TREM2 targeting small molecule Sob-AM2 improves cognition independent of Aβ plaque alteration in 5xFAD miceSemantic proximity Read ↗

Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of Neuroinflammation Effective in Alzheimer's Disease Models.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.